Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Total Debt Over TimeNormalizing
Percentile Rank40
3Y CAGR-14.3%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
-14.3%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineNormalizing
PeriodValueYoY Change
2024$1.81M-34.9%
2023$2.79M-23.7%
2022$3.65M+26.6%
2021$2.88M+77.6%
2020$1.62M-
2019$0.00-